BIOGEN INC. Unrealized Gain (Loss) on Investments
BIOGEN INC. (BIIB) reported Unrealized Gain (Loss) on Investments of -$681.80 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2021-02-03
- BIOGEN INC. unrealized gain (loss) on investments for the quarter ending 2020-09-30 was -$82.10M, a 303.72% decline year-over-year.
- BIOGEN INC. unrealized gain (loss) on investments for the quarter ending 2019-09-30 was $40.30M.
- BIOGEN INC. unrealized gain (loss) on investments for fiscal 2020 was -$681.80M, a 554.23% decline from fiscal 2019.
- BIOGEN INC. unrealized gain (loss) on investments for fiscal 2019 was $150.10M.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|
| 2020-12-31 | -$681.80M 10-K · filed 2021-02-03 | |
| 2020-09-30 | -$82.10M 10-Q · filed 2020-10-21 | |
| 2019-12-31 | $150.10M 10-K · filed 2021-02-03 | |
| 2019-09-30 | $40.30M 10-Q · filed 2020-10-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |